The myth was created in the 1960s.There is a kind of 'holy ground' in the policy discourse of early childhood education.These ...

Adults with severe asthma who used biologics had lower risks for major adverse cardiovascular events than those on other ...

Sole recipient in his award subcategory, representing an approximately 3.8% recipient rate, recognized for contributio ...

That makes it a practical option for people who find traditional workouts difficult because of pain, limited mobility, or ...

ALPHA | Overview of Technology◾️What is ICL Group's SciTech?Technology to convert Dead Sea mineral resources into functional ...

(Oleg Breslavtsev/Moment RF/Getty Images) Type 2 diabetes is not necessarily a lifelong diagnosis or a disease that gets progressively worse over time. Today, there is strong evidence to suggest that ...

Deep-sea holobionts adapt to extreme environmental fluctuations, but the molecular mechanisms underlying resilience remain poorly understood. We investigated the vesicomyid clam Archivesica ...

Top prizes went for an icy window into the cosmos, a light switch for the brain and solving the mystery of mirror image ...

Halley Froehlich was sure she’d spend her scientific career in the United States. Her family has been in America since the ...

SpyGlass Pharma has reported 4-year interim results from the first-in-human (FIH) trial of its Bimatoprost Drug Pad-IOL System (BIM-IOL System), extending what the company describes as the “longest ...

Rollins (ROL) rated Buy with $57 target: contrarian upside after misses. 75% recurring revenue, secular tailwinds; key risks flagged. Click here to read.

Democrats built a major fundraising edge in key Senate races in the third quarter, but GOP outside spending remains strong.